NASDAQ:SKIN
The Beauty Health Company
- Stock
Last Close
1.39
22/11 21:00
Market Cap
217.59M
Beta: 1.13
Volume Today
497.07K
Avg: 1.90M
PE Ratio
−4.40
PFCF: 36.08
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 21.32M - | 29.23M 37.12% | 75.85M 159.46% | 103.88M 36.96% | |||
average payables | 16.37M - | 23.77M 45.18% | 29.69M 24.93% | 37.55M 26.47% | |||
average receivables | 23.45M - | 37.30M 59.06% | 64.60M 73.16% | 66.24M 2.53% | |||
book value per share | -0.01 - | -0.24 2,380.13% | 2.96 1,339.08% | 1.16 60.74% | 0.45 61.19% | ||
capex per share | -0.06 - | -0.08 32.18% | -0.03 63.38% | -0.15 402.41% | -0.12 22.92% | ||
capex to depreciation | -0.69 - | -0.75 9.47% | -0.27 64.70% | -0.74 178.76% | -0.79 6.93% | ||
capex to operating cash flow | 8.81 - | -6.03 168.46% | 0.31 105.09% | 0.55 79.39% | 0.16 70.37% | ||
capex to revenue | -0.07 - | -0.06 10.91% | -0.03 48.76% | -0.06 87.33% | -0.05 20.82% | ||
cash per share | 0.06 - | 0.08 29.54% | 8.83 11,600.97% | 3.85 56.40% | 3.97 3.15% | ||
days of inventory on hand | 118.01 - | 163.20 38.29% | 164.46 0.77% | 367.82 123.66% | 137.24 62.69% | ||
days payables outstanding | 86.57 - | 130.02 50.19% | 135.48 4.20% | 95.83 29.27% | 67.28 29.80% | ||
days sales outstanding | 51.96 - | 71.06 36.77% | 72.17 1.55% | 77.59 7.51% | 50.16 35.35% | ||
debt to assets | 0.84 - | 0.97 15.90% | 0.60 38.06% | 0.75 23.80% | 0.81 8.66% | ||
debt to equity | -157.10 - | -7.23 95.40% | 2.43 133.58% | 4.38 80.66% | 12.67 188.92% | ||
dividend yield | 0.07 - | ||||||
earnings yield | -0.00 - | -0.00 416.72% | -0.02 1,607.10% | -0.15 639.13% | 0.03 121.74% | -0.24 839.58% | |
enterprise value | 1.54B - | 1.63B 5.42% | 2.30B 41.21% | 1.53B 33.50% | 638.79M 58.15% | ||
enterprise value over ebitda | 55.30 - | -574.73 1,139.19% | -26.03 95.47% | -91.10 250.04% | -4.88 94.64% | ||
ev to operating cash flow | 892.24 - | -130.69 114.65% | -80.93 38.08% | -14.32 82.31% | 29.37 305.12% | ||
ev to sales | 9.25 - | 13.65 47.49% | 8.82 35.34% | 4.17 52.73% | 1.61 61.53% | ||
free cash flow per share | -0.07 - | -0.07 0.98% | -0.13 86.95% | -0.43 232.28% | -0.84 95.13% | 0.17 119.66% | |
free cash flow yield | -0.01 - | -0.01 0.98% | -0.01 79.17% | -0.02 55.55% | -0.09 418.05% | 0.05 157.51% | |
graham net net | -1.54 - | -1.71 11.20% | 0.41 123.82% | -1.03 354.16% | -1.97 90.82% | ||
graham number | 0.05 - | 1.12 2,001.77% | 15.64 1,298.71% | 2.80 82.07% | 2.78 0.96% | ||
income quality | 2.82 - | -1.05 137.37% | 0.43 140.41% | 0.08 82.26% | -2.40 3,276.62% | -0.22 90.95% | |
intangibles to total assets | 0 - | 0.70 Infinity% | 0.67 4.40% | 0.15 78.02% | 0.17 14.94% | 0.20 19.36% | |
interest coverage | 1.00 - | 0.79 21.32% | -0.81 202.54% | -3.11 285.22% | -1.81 41.72% | -9.59 429.04% | |
interest debt per share | 1.65 - | 1.90 14.96% | 7.30 284.92% | 5.19 28.96% | 5.82 12.17% | ||
inventory turnover | 3.09 - | 2.24 27.69% | 2.22 0.77% | 0.99 55.29% | 2.66 168.02% | ||
invested capital | -157.10 - | -7.23 95.40% | 2.43 133.58% | 4.38 80.66% | 12.67 188.92% | ||
market cap | 1.36B - | 1.36B 0% | 1.42B 4.34% | 2.47B 73.95% | 1.34B 45.57% | 409.53M 69.50% | |
net current asset value | -173.39M - | -193.70M 11.71% | 84.38M 143.56% | -48.33M 157.28% | -171.47M 254.78% | ||
net debt to ebitda | 6.55 - | -73.21 1,218.58% | 1.95 102.66% | -10.96 661.91% | -1.75 84.02% | ||
net income per share | -0.00 - | -0.01 416.72% | -0.23 1,681.14% | -3.67 1,478.90% | 0.30 108.19% | -0.76 352.76% | |
operating cash flow per share | -0.01 - | 0.01 293.07% | -0.10 819.68% | -0.28 180.06% | -0.72 160.12% | 0.17 122.86% | |
payables turnover | 4.22 - | 2.81 33.42% | 2.69 4.03% | 3.81 41.37% | 5.43 42.44% | ||
receivables turnover | 7.02 - | 5.14 26.89% | 5.06 1.53% | 4.70 6.99% | 7.28 54.67% | ||
research and ddevelopement to revenue | 0.02 - | 0.03 29.37% | 0.03 3.37% | 0.03 10.07% | 0.02 26.75% | 0.03 9.98% | |
return on tangible assets | -0.02 - | -0.40 1,539.58% | -0.36 9.22% | 0.05 114.67% | -0.14 355.01% | ||
revenue per share | 0.90 - | 1.33 48.36% | 0.95 28.53% | 2.55 168.19% | 2.48 2.65% | 3.02 21.89% | |
roe | 1.36 - | 0.97 28.18% | -1.24 227.42% | 0.26 120.86% | -1.69 751.28% | ||
roic | 0.04 - | -0.07 275.62% | -0.03 50.43% | -0.03 26.51% | -0.16 512.63% | ||
sales general and administrative to revenue | 0.16 - | 0.16 1.12% | 0.26 60.83% | 0.38 47.44% | 0.29 23.58% | 0.33 13.88% | |
shareholders equity per share | -0.01 - | -0.24 2,380.13% | 2.96 1,339.08% | 1.16 60.74% | 0.45 61.19% | ||
stock based compensation to revenue | 0.00 - | 0.00 13.81% | 0.00 393.08% | 0.05 1,466.43% | 0.08 63.12% | 0.06 27.27% | |
tangible asset value | -160.02M - | -179.43M 12.13% | 122.59M 168.33% | 497K 99.59% | -128.55M 25,965.39% | ||
tangible book value per share | -1.28 - | -1.43 12.13% | 1.20 183.91% | 0.00 99.72% | -0.98 29,083.35% | ||
working capital | 16.35M - | 28.16M 72.24% | 924.46M 3,182.28% | 715.98M 22.55% | 583.24M 18.54% |
All numbers in USD (except ratios and percentages)